BR112014017630A8 - Métodos para a determinação de presença e/ou da quantidade de um antígeno - Google Patents
Métodos para a determinação de presença e/ou da quantidade de um antígenoInfo
- Publication number
- BR112014017630A8 BR112014017630A8 BR112014017630A BR112014017630A BR112014017630A8 BR 112014017630 A8 BR112014017630 A8 BR 112014017630A8 BR 112014017630 A BR112014017630 A BR 112014017630A BR 112014017630 A BR112014017630 A BR 112014017630A BR 112014017630 A8 BR112014017630 A8 BR 112014017630A8
- Authority
- BR
- Brazil
- Prior art keywords
- antigen
- antibody
- determining
- methods
- sample
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
Abstract
MÉTODOS PARA A DETERMINAÇÃO DA PRESENÇA E/OU DA QUANTIDADE DE UM ANTÍGENO. A presente invenção se refere a um método para a detecção do antígeno livre de um anticorpo multiespecífico em uma amostra, em que o antígeno a ser detectado pode ser especificamente ligado por um primeiro local de ligação do anticorpo multiespecífico, que compreende a etapa da incubação de uma amostra que compreende o antígeno livre e o anticorpo multiespecífico com um anticorpo anti-idiotípico especificamente ligado a uma segunda especificidade de ligação do anticorpo biespecífico, que é diferente da primeira especificidade de ligação, em que o anticorpo anti-idiotípico é ligado a uma fase sólida.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12153457 | 2012-02-01 | ||
EP12182505 | 2012-08-31 | ||
PCT/EP2013/051604 WO2013113663A1 (en) | 2012-02-01 | 2013-01-29 | Method for the detection of a binding partner of a multispecific binder |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014017630A2 BR112014017630A2 (pt) | 2017-06-20 |
BR112014017630A8 true BR112014017630A8 (pt) | 2017-07-11 |
Family
ID=47624068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014017630A BR112014017630A8 (pt) | 2012-02-01 | 2013-01-29 | Métodos para a determinação de presença e/ou da quantidade de um antígeno |
Country Status (11)
Country | Link |
---|---|
US (3) | US9945869B2 (pt) |
EP (1) | EP2810074B1 (pt) |
JP (3) | JP2015507193A (pt) |
KR (1) | KR20140128314A (pt) |
CN (2) | CN104105966B (pt) |
BR (1) | BR112014017630A8 (pt) |
CA (1) | CA2859268A1 (pt) |
HK (1) | HK1202921A1 (pt) |
MX (1) | MX349661B (pt) |
RU (1) | RU2620563C2 (pt) |
WO (1) | WO2013113663A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015507193A (ja) | 2012-02-01 | 2015-03-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 多重特異性結合物の結合パートナーを検出するための方法 |
RU2636822C2 (ru) | 2012-07-13 | 2017-11-28 | Ф.Хоффманн-Ля Рош Аг | Способ обнаружения мультиспецифического связывающего агента |
JP6446044B2 (ja) | 2013-11-05 | 2018-12-26 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 結合分子の存在下で被検体の総量および/または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用 |
CN104109197B (zh) * | 2013-11-13 | 2017-05-10 | 叶森 | 一种双识别抗体片段的制备方法及其应用 |
SI3356411T1 (sl) | 2015-10-02 | 2021-09-30 | F. Hoffmann-La Roche Ag | Bispecifična protitelesa, specifična za PD1 in TIM3 |
JP6734919B2 (ja) | 2015-10-02 | 2020-08-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 同時結合を測定するための細胞ベースのfretアッセイ法 |
BR112019017329A2 (pt) | 2017-04-03 | 2020-04-14 | Hoffmann La Roche | imunoconjugados, um ou mais polinucleotídeos e vetores, métodos para a produção de um imunoconjugado, tratamento de uma doença e para a estimulação do sistema imunológico, composição, uso do imunoconjugado, invenção e usos da composição |
CN116375876A (zh) | 2017-04-05 | 2023-07-04 | 豪夫迈·罗氏有限公司 | 特异性结合pd1和lag3的双特异性抗体 |
EP3805757A4 (en) | 2018-06-04 | 2022-03-23 | Chugai Seiyaku Kabushiki Kaisha | METHOD FOR DETECTING A COMPLEX |
EP3969907A1 (en) * | 2019-05-13 | 2022-03-23 | F. Hoffmann-La Roche AG | Interference-suppressed pharmacokinetic immunoassay |
WO2022065052A1 (ja) * | 2020-09-24 | 2022-03-31 | 株式会社Jvcケンウッド | 捕捉用抗体、固相担体、検出用抗体、固相担体粒子、並びに検出対象物質の測定キット及び測定方法 |
CN117805397A (zh) * | 2024-02-29 | 2024-04-02 | 军科正源(北京)药物研究有限责任公司 | 检测游离vegf的方法 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219730A (en) | 1982-09-28 | 1993-06-15 | New York University | Idiotype-anti-idiotype immunoassay |
US4828981A (en) | 1983-08-24 | 1989-05-09 | Synbiotics Corporation | Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents |
EP0170302A1 (fr) | 1984-06-27 | 1986-02-05 | l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire | Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques |
US5238808A (en) | 1984-10-31 | 1993-08-24 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
EP0243471A4 (en) | 1985-10-22 | 1989-07-11 | Cooper Lipotech Inc | SOLID PHASE LIPOSOME IMMUNOANALYSIS SYSTEM. |
US5068088A (en) | 1988-11-03 | 1991-11-26 | Igen, Inc. | Method and apparatus for conducting electrochemiluminescent measurements |
KR0143993B1 (ko) | 1988-11-03 | 1998-07-15 | 리차아드 제이 매씨이 | 전기화학 발광성 분석 |
IL100866A (en) | 1991-02-06 | 1995-10-31 | Igen Inc | Luminescence test method and device based on magnetic tiny particles, containing many magnets |
JPH07509128A (ja) | 1992-07-13 | 1995-10-12 | バイオネブラスカ・インコーポレーテッド | 組換型ポリペプチドの修飾方法 |
JPH097096A (ja) | 1995-06-20 | 1997-01-10 | Alpine Electron Inc | 緊急車両接近時の報知方法 |
JPH0975096A (ja) * | 1995-09-14 | 1997-03-25 | Snow Brand Milk Prod Co Ltd | ラクトフェリンの測定法 |
AU757691B2 (en) * | 1997-11-21 | 2003-03-06 | Inverness Medical Switzerland Gmbh | Improvements in or relating to displacement assays |
JPH11352129A (ja) * | 1998-06-04 | 1999-12-24 | Mizuho Medeii:Kk | 検出装置及び検出方法 |
US6753189B1 (en) | 1998-06-04 | 2004-06-22 | Mizuho Medy Co., Ltd. | Detection apparatus and method for the same |
ATE315789T1 (de) * | 1999-11-16 | 2006-02-15 | Genentech Inc | Elisa für vegf |
GB0007088D0 (en) * | 2000-03-23 | 2000-05-17 | Torsana A S | Detection of immunological memory determining the position of loci of pathologyand therapeutic t-cell conjugates |
US6984494B2 (en) | 2000-08-15 | 2006-01-10 | Genentech, Inc. | Analytical method |
US7341837B2 (en) | 2003-09-02 | 2008-03-11 | Lawton Robert L | Soluble analyte detection and amplification |
US20080206782A1 (en) | 2005-03-08 | 2008-08-28 | Genentech, Inc. | Methods for Determining the Bivalency of Protein and Antibody Therapeutics |
US7494776B2 (en) | 2005-07-07 | 2009-02-24 | Beckman Coulter, Inc. | Labeled complementary oligonucleotides to detect oligonucleotide-linked ligands |
ZA200801154B (en) * | 2005-07-21 | 2009-07-29 | Genmab As | Potency assays for antibody drug substance binding to an FC receptor |
ES2530265T3 (es) | 2005-07-21 | 2015-02-27 | Genmab A/S | Ensayos de potencia de unión de una sustancia medicamentosa de anticuerpo a un receptor FC |
SI2457929T1 (sl) * | 2006-10-04 | 2016-09-30 | Genentech, Inc. | ELISA za VEGF |
EP1917854A1 (en) | 2006-11-06 | 2008-05-07 | F. Hoffmann-La Roche Ag | Method for producing anti idiotypic antibodies |
US8242247B2 (en) | 2007-12-21 | 2012-08-14 | Hoffmann-La Roche Inc. | Bivalent, bispecific antibodies |
US8227577B2 (en) | 2007-12-21 | 2012-07-24 | Hoffman-La Roche Inc. | Bivalent, bispecific antibodies |
US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
JP2011523853A (ja) | 2008-06-03 | 2011-08-25 | アボット・ラボラトリーズ | 二重可変ドメイン免疫グロブリン及びその使用 |
JP5634405B2 (ja) * | 2008-10-07 | 2014-12-03 | ユィロス・パテント・アクチボラグGyros Patent AB | 試料中のアナライトの検出のための半逐次アッセイ |
EP2414391B1 (en) | 2009-04-02 | 2018-11-28 | Roche Glycart AG | Multispecific antibodies comprising full length antibodies and single chain fab fragments |
WO2010115589A1 (en) | 2009-04-07 | 2010-10-14 | Roche Glycart Ag | Trivalent, bispecific antibodies |
AU2010252284A1 (en) | 2009-05-27 | 2011-11-17 | F. Hoffmann-La Roche Ag | Tri- or tetraspecific antibodies |
US9676845B2 (en) | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
US8703132B2 (en) | 2009-06-18 | 2014-04-22 | Hoffmann-La Roche, Inc. | Bispecific, tetravalent antigen binding proteins |
ES2628839T3 (es) * | 2009-10-19 | 2017-08-04 | F. Hoffmann-La Roche Ag | Anticuerpos anti-IgG sin reactividad cruzada |
CN102207504A (zh) * | 2011-03-23 | 2011-10-05 | 北京华创远航科技有限公司 | 一种酶联检测试剂盒及其制备方法 |
CA2853917A1 (en) | 2011-12-19 | 2013-06-27 | F. Hoffmann-La Roche Ag | Method for the detection of free binding partner of a multispecific binder |
JP2015507193A (ja) | 2012-02-01 | 2015-03-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 多重特異性結合物の結合パートナーを検出するための方法 |
US20130231462A1 (en) * | 2012-02-27 | 2013-09-05 | Bio-Rad Laboratories, Inc. | Anti-immune complex antibodies |
RU2636822C2 (ru) | 2012-07-13 | 2017-11-28 | Ф.Хоффманн-Ля Рош Аг | Способ обнаружения мультиспецифического связывающего агента |
-
2013
- 2013-01-29 JP JP2014555164A patent/JP2015507193A/ja active Pending
- 2013-01-29 CA CA2859268A patent/CA2859268A1/en not_active Abandoned
- 2013-01-29 KR KR1020147021674A patent/KR20140128314A/ko not_active Application Discontinuation
- 2013-01-29 MX MX2014008762A patent/MX349661B/es active IP Right Grant
- 2013-01-29 BR BR112014017630A patent/BR112014017630A8/pt not_active IP Right Cessation
- 2013-01-29 WO PCT/EP2013/051604 patent/WO2013113663A1/en active Application Filing
- 2013-01-29 EP EP13701628.3A patent/EP2810074B1/en active Active
- 2013-01-29 CN CN201380007278.5A patent/CN104105966B/zh active Active
- 2013-01-29 CN CN201610880999.2A patent/CN106443016B/zh active Active
- 2013-01-29 RU RU2014133701A patent/RU2620563C2/ru not_active IP Right Cessation
-
2014
- 2014-08-01 US US14/449,437 patent/US9945869B2/en active Active
-
2015
- 2015-04-01 HK HK15103324.4A patent/HK1202921A1/xx unknown
-
2017
- 2017-08-29 JP JP2017163827A patent/JP6502441B2/ja active Active
-
2018
- 2018-03-16 US US15/923,773 patent/US10761097B2/en active Active
-
2019
- 2019-03-20 JP JP2019052527A patent/JP6678792B2/ja active Active
-
2020
- 2020-07-31 US US16/945,730 patent/US20210055304A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2017223710A (ja) | 2017-12-21 |
JP6678792B2 (ja) | 2020-04-08 |
BR112014017630A2 (pt) | 2017-06-20 |
CN106443016B (zh) | 2019-08-13 |
US20210055304A1 (en) | 2021-02-25 |
CN104105966A (zh) | 2014-10-15 |
EP2810074A1 (en) | 2014-12-10 |
WO2013113663A1 (en) | 2013-08-08 |
RU2620563C2 (ru) | 2017-05-26 |
US20180328942A1 (en) | 2018-11-15 |
CN104105966B (zh) | 2016-10-26 |
KR20140128314A (ko) | 2014-11-05 |
US20140342382A1 (en) | 2014-11-20 |
HK1202921A1 (en) | 2015-10-09 |
CA2859268A1 (en) | 2013-08-08 |
JP2015507193A (ja) | 2015-03-05 |
CN106443016A (zh) | 2017-02-22 |
MX349661B (es) | 2017-08-08 |
US10761097B2 (en) | 2020-09-01 |
US9945869B2 (en) | 2018-04-17 |
JP6502441B2 (ja) | 2019-04-17 |
EP2810074B1 (en) | 2017-08-23 |
JP2019113564A (ja) | 2019-07-11 |
RU2014133701A (ru) | 2016-03-27 |
MX2014008762A (es) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014017630A8 (pt) | Métodos para a determinação de presença e/ou da quantidade de um antígeno | |
BR112014008382A2 (pt) | anticorpo especificamente ligando a epítope no domínio sema do c-met | |
BR112016029634A2 (pt) | kit, dispositivo e método para a detecção de câncer de fígado | |
EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
MX349003B (es) | Metodo para la deteccion del asociado de union libre de un aglutinante multiespecifico. | |
BR112014025384A8 (pt) | método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares | |
EA201600085A1 (ru) | Набор для обнаружения соевого события syht0h2 | |
BR112014002616A2 (pt) | método para detectar cãncer pancreático e reagente ou kit para detectar câncer pancreático | |
BR112014018831A2 (pt) | método para otimizar sensibilidade e/ou seletividade de um sensor para um ou mais analitos, método para formar um sensor para um ou mais analitos, kit para a detecção de um ou mais analitos, método de identificação de um aptâmero, composição de matéria e aptâmeros. | |
BR112013021666A2 (pt) | detecção de capacitância em ensaio eletroquímico com compensação de tempo de amostragem aprimorada | |
MX2014015847A (es) | Pruebas de cemento. | |
MX364410B (es) | Metodo para detectar nucleosomas que contienen nucleotidos. | |
BR112012021590A2 (pt) | detecção de capacitância em ensaio eletroquímico | |
BR112014012590A8 (pt) | Anticorpos anti-cd98 e métodos de uso dos mesmos | |
BRPI0906573A2 (pt) | Método para determinação da sensibilidade para agentes anticâncer | |
MX353954B (es) | Aptameros y metodos de diagnostico para detectar el receptor del factor de crecimiento epidermal (egf). | |
RU2015104737A (ru) | Способ обнаружения мультиспецифического связывающего агента | |
BR112016002668A2 (pt) | métodos e kits para prognosticar o risco de ter uma doença ou evento cardiovasculares | |
BR112014009223A8 (pt) | método para o diagnóstico da doença de niemann-pick | |
BR112017021186A2 (pt) | ?método para detectar a presença de bactérias produtoras de beta-lactamase? | |
BR112018007842A2 (pt) | imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk) | |
BR112014031958A2 (pt) | bag3 como marcador de tecido e soro bioquímico | |
MX2016002529A (es) | Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica. | |
WO2012145516A3 (en) | Methods and kits for quantitative determination of total organic acid content in a coolant | |
BRPI1009460A2 (pt) | domínio de ligação do anticorpo, anticorpo, uso de um domínio de ligação ou anticorpo, método para detectar a presença de células cancerígenas em uma amostra. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2551 DE 26-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |